153 related articles for article (PubMed ID: 24675833)
1. Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulation.
Wen F; Ma JH; Yu H; Yang FR; Huang M; Zhou YJ; Li ZJ; Tong GZ
J Vet Sci; 2014; 15(3):381-8. PubMed ID: 24675833
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
[TBL] [Abstract][Full Text] [Related]
4. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
[TBL] [Abstract][Full Text] [Related]
5. Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.
Kitikoon P; Gauger PC; Anderson TK; Culhane MR; Swenson S; Loving CL; Perez DR; Vincent AL
Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):32-41. PubMed ID: 24224818
[TBL] [Abstract][Full Text] [Related]
6. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.
Loving CL; Lager KM; Vincent AL; Brockmeier SL; Gauger PC; Anderson TK; Kitikoon P; Perez DR; Kehrli ME
J Virol; 2013 Sep; 87(17):9895-903. PubMed ID: 23824815
[TBL] [Abstract][Full Text] [Related]
7. The inactivated vaccine of reassortant H3N2 canine influenza virus based on internal gene cassette from PR8 is safe and effective.
Liu Y; Fu C; Ye S; Liang Y; Qi Z; Yao C; Wang Z; Wang J; Cai S; Tang S; Chen Y; Li S
Vet Microbiol; 2021 Mar; 254():108997. PubMed ID: 33524810
[TBL] [Abstract][Full Text] [Related]
8. A bivalent live attenuated influenza virus vaccine protects against H1N2 and H3N2 viral infection in swine.
Landreth S; Detmer S; Gerdts V; Zhou Y
Vet Microbiol; 2021 Feb; 253():108968. PubMed ID: 33418392
[TBL] [Abstract][Full Text] [Related]
9. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.
Ruan BY; Yao Y; Wang SY; Gong XQ; Liu XM; Wang Q; Yu LX; Zhu SQ; Wang J; Shan TL; Zhou YJ; Tong W; Zheng H; Li GX; Gao F; Kong N; Yu H; Tong GZ
Vet Microbiol; 2020 Jul; 246():108724. PubMed ID: 32605742
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
[TBL] [Abstract][Full Text] [Related]
12. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
13. A novel M2e-multiple antigenic peptide providing heterologous protection in mice.
Wen F; Ma JH; Yu H; Yang FR; Huang M; Zhou YJ; Li ZJ; Wang XH; Li GX; Jiang YF; Tong W; Tong GZ
J Vet Sci; 2016 Mar; 17(1):71-8. PubMed ID: 27051342
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
[TBL] [Abstract][Full Text] [Related]
15. Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States.
Rajão DS; Gauger PC; Anderson TK; Lewis NS; Abente EJ; Killian ML; Perez DR; Sutton TC; Zhang J; Vincent AL
J Virol; 2015 Nov; 89(22):11213-22. PubMed ID: 26311895
[TBL] [Abstract][Full Text] [Related]
16. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge.
Tian ZJ; Zhou GH; Zheng BL; Qiu HJ; Ni JQ; Yang HL; Yin XN; Hu SP; Tong GZ
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):211-8. PubMed ID: 16621018
[TBL] [Abstract][Full Text] [Related]
17. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
[TBL] [Abstract][Full Text] [Related]
18. Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs.
Xu J; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Chen W; Lu C
Vet Microbiol; 2013 Feb; 162(1):259-64. PubMed ID: 23265244
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.
Vincent AL; Ma W; Lager KM; Janke BH; Webby RJ; García-Sastre A; Richt JA
Vaccine; 2007 Nov; 25(47):7999-8009. PubMed ID: 17933442
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
